Marc Arbyn
Marc Arbyn is an expert in Oncology at Institut Scientifique de Santé Publique (Belgium). As of October 2026, ScienceLeadR ranks Marc Arbyn in the top 1% of experts worldwide for Uterine Diseases. Marc Arbyn has authored 439 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 3 of them ongoing. SLR score: 1,843 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Gynecology - Infectiology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2000 - 2026
Number : 439
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Response to letter Re: Diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis. PMID 42945741 — research design, diagnostic techniques and procedures, uterine cervical neoplasms, neoplasms, dna methylation | Eur J Cancer | 2026 | 0 |
| How to evaluate and select cervical screening and triage tests in vaccinated populations. PMID 42670622 — vaccines, triage, neoplasms, biomarkers, alphapapillomavirus, infections, human papillomavirus viruses | J Natl Cancer Inst Monogr | 2026 | 2 |
| Clinical Validation of the Sansure Human Papillomavirus DNA Diagnostic Kit for Use in Primary Cervical Cancer Screening. PMID 42605738 — laboratories, uterine cervical neoplasms, virology, neoplasms, alphapapillomavirus, human papillomavirus viruses | J Med Virol | 2026 | 0 |
| Cancer Risk Profile of the Levonorgestrel-Releasing Intrauterine Device: A Narrative Review. PMID 42588595 — registries, breast neoplasms, uterine cervical neoplasms, case-control studies, ovary, neoplasms, levonorgestrel, ovarian neoplasms, breast, intrauterine devices, endometrial neoplasms | Cancers (Basel) | 2026 | 0 |
| Primary Human Papillomavirus Screening Versus Cytology for Detection of Cervical Intraepithelial Neoplasia Grade 2 or Higher in Poland: a Parallel-Group, Randomized Controlled Trial. PMID 42403920 — research design, triage, neoplasms, cell biology, alphapapillomavirus, colposcopy, cytology, human papillomavirus viruses | Lancet Reg Health Eur | 2026 | 1 |
Clinical Studies 6
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Efficacy of Offering a Self sampling Device by the GP to Reach Underscreened Women NCT05656976 — general practitioners, uterine cervical neoplasms, neoplasms, pamphlets, papilloma, viruses, alphapapillomavirus, human papillomavirus viruses, women | N/A | Active not recruiting | 2023 |
| Clinical Validation of Molecular Triage in HR HPV Positive Women NCT05193669 — triage, papanicolaou test, carcinoma, women | N/A | Active not recruiting | 2021 |
| Increase in Response by Offering Self sampling Devices in Belgian GP Practices to Non screened Women NCT04903561 — uterine cervical neoplasms, neoplasms, informed consent, women | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map